Abstract
The assessment of asthma in children is critical to determining when to start, stop and adjust daily antiinflammatory controller medications, and to achieving optimal asthma outcomes. Several key aspects of asthma management are discussed including; 1) establishing a diagnosis of asthma, 2) classifying asthma severity or control, 3) assigning treatment (e.g., determining which patients are in need of daily controller medications), and 4) evaluating how well a patient is responding to prescribed asthma therapy. Use of validated control measures has been encouraged in the 2007 EPR-3 NIH asthma guidelines as means of facilitating the assessment of asthma control. Several measures of asthma control are included for use in clinical practice.
Keywords: Asthma severity, asthma control, asthma diagnosis
Current Pediatric Reviews
Title: Update of Asthma Assessment in Children
Volume: 8 Issue: 1
Author(s): Sande Okelo
Affiliation:
Keywords: Asthma severity, asthma control, asthma diagnosis
Abstract: The assessment of asthma in children is critical to determining when to start, stop and adjust daily antiinflammatory controller medications, and to achieving optimal asthma outcomes. Several key aspects of asthma management are discussed including; 1) establishing a diagnosis of asthma, 2) classifying asthma severity or control, 3) assigning treatment (e.g., determining which patients are in need of daily controller medications), and 4) evaluating how well a patient is responding to prescribed asthma therapy. Use of validated control measures has been encouraged in the 2007 EPR-3 NIH asthma guidelines as means of facilitating the assessment of asthma control. Several measures of asthma control are included for use in clinical practice.
Export Options
About this article
Cite this article as:
Okelo Sande, Update of Asthma Assessment in Children, Current Pediatric Reviews 2012; 8 (1) . https://dx.doi.org/10.2174/157339612799746344
DOI https://dx.doi.org/10.2174/157339612799746344 |
Print ISSN 1573-3963 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6336 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Resolution of Empyema Thoracis after Patient Refusal of Surgical Intervention: A Case Series and Review of the Literature
Current Respiratory Medicine Reviews Leptin and the Ob-Receptor as Anti-Obesity Target: Recent In Silico Advances in the Comprehension of the Protein-Protein Interaction and Rational Drug Design of Anti- Obesity Lead Compounds
Current Pharmaceutical Design Herbal Nano Formulations: Patent and Regulatory Overview
Applied Clinical Research, Clinical Trials and Regulatory Affairs Leukotriene C4 Synthase: Upcoming Drug Target For Inflammation
Current Drug Targets Multimodal Optical, X-Ray CT, and SPECT Imaging of a Mouse Model of Breast Cancer Lung Metastasis
Current Molecular Medicine Real-life Experience of Clinical Efficacy of Omalizumab Use in the MiddleEast: Should We Also Be Concerned About Parasites?
Clinical Anti-Inflammatory & Anti-Allergy Drugs (Discontinued) HspB1 Dynamic Phospho-Oligomeric Structure Dependent Interactome as Cancer Therapeutic Target
Current Molecular Medicine Metabolic Syndrome and Asthma
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Clinical and Forensic Signs Related to Opioids Abuse
Current Drug Abuse Reviews State of the Art Clinical Efficacy and Safety Evaluation of N-Acetylcarnosine Dipeptide Ophthalmic Prodrug. Principles for the Delivery, Self-Bioactivation, Molecular Targets and Interaction with a Highly Evolved Histidyl-Hydrazide Structure in the Treatment and Therapeutic Management of a Group of Sight-Threatening Eye Diseases
Current Clinical Pharmacology Role of Toll-Like Receptors in Immune Responses to Chlamydial Infections
Current Pharmaceutical Design Lesions and Dysfunctions of the Nucleus Basalis as Alzheimers Disease Models: General and Critical Overview and Analysis of the Long-Term Changes in Several Excitotoxic Models
Current Alzheimer Research Management of Food-Induced Anaphylaxis: Unsolved Challenges
Current Clinical Pharmacology HPLC-NMR Chemical Profiling of the Australian Carnivorous Plant, Drosera erythrohiza subspecies magna
The Natural Products Journal Gastrin-Releasing Peptide as a Molecular Target for Inflammatory Diseases: An Update
Inflammation & Allergy - Drug Targets (Discontinued) Pharmacological Targeting of Neuronal Kv7.2/3 Channels: A Focus on Chemotypes and Receptor Sites
Current Medicinal Chemistry Isoform Selective Phosphoinositide 3-Kinase γ and δ Inhibitors and Their Therapeutic Potential
Recent Patents on Inflammation & Allergy Drug Discovery Antisense Therapy for Cardiovascular Diseases
Current Pharmaceutical Design Toll Like Receptor - Potential Drug Targets in Infectious Disease
Infectious Disorders - Drug Targets Antisense Oligonucleotide Drug Design
Current Pharmaceutical Design